A Combination of Glucagon-Like Peptide-1 Receptor Agonist and Dietary Intervention Could Be a Promising Approach for Obesity Treatment

被引：4
作者：
Lee, Chooi Yeng [1 ]
机构：
[1] Monash Univ Malaysia, Sch Pharm, Subang Jaya, Malaysia
来源：
FRONTIERS IN ENDOCRINOLOGY | 2021年 / 12卷
关键词：
combination therapy; diet; glucagon-like peptide-1 agonist; gut-brain axis; obesity; LAPAROSCOPIC SLEEVE GASTRECTOMY; WEIGHT-LOSS; GLUCOSE-INTOLERANCE; GLP-1; SECRETION; GASTRIC BYPASS; GUT MICROBIOTA; INFLAMMATION; INGESTION; GHRELIN; LEPTIN;
D O I：
10.3389/fendo.2021.748477
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：6
相关论文
共 50 条
  • [31] Sleep is increased by liraglutide, a glucagon-like peptide-1 receptor agonist, in rats
    Fang, Jidong
    Miller, Patti
    Grigson, Patricia S.
    BRAIN RESEARCH BULLETIN, 2023, 192 : 142 - 155
  • [32] Association of glucagon-like peptide-1 receptor-targeted imaging probe with in vivo glucagon-like peptide-1 receptor agonist glucose-lowering effects
    Murakami, Takaaki
    Fujimoto, Hiroyuki
    Fujita, Naotaka
    Hamamatsu, Keita
    Yabe, Daisuke
    Inagaki, Nobuya
    JOURNAL OF DIABETES INVESTIGATION, 2020, 11 (06) : 1448 - 1456
  • [33] The effects of Fc fusion protein glucagon-like peptide-1 and glucagon dual receptor agonist with different receptor selectivity in vivo studies
    Jiang, Peng
    Zeng, Ying
    Yang, Wen
    Li, Lijia
    Zhou, Linjun
    Li, Yong
    Gu, Baohua
    Li, Xiaoping
    Li, Jing
    Li, Wenjia
    Guo, Linfeng
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 174
  • [34] Oral Semaglutide, the First Ingestible Glucagon-Like Peptide-1 Receptor Agonist: Could It Be a Magic Bullet for Type 2 Diabetes?
    Kim, Hwi Seung
    Jung, Chang Hee
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (18)
  • [35] Glucagon-Like Peptide-1 Agonists
    Stanton, Eloise W.
    Manasyan, Artur
    Banerjee, Rakhi
    Hong, Kurt
    Koesters, Emma
    Daar, David A.
    ANNALS OF PLASTIC SURGERY, 2025, 94 (01) : 121 - 127
  • [36] Glucagon-like peptide-1 (GLP-1) receptor agonists, obesity and psoriasis: diabetes meets dermatology
    Drucker, D. J.
    Rosen, C. F.
    DIABETOLOGIA, 2011, 54 (11) : 2741 - 2744
  • [37] Effect of Antidepressants on Glucagon-Like Peptide-1 Receptor Agonist-Related Weight Loss
    Durell, Natalie
    Franks, Rachel
    Coon, Scott
    Cowart, Kevin
    Carris, Nicholas W.
    JOURNAL OF PHARMACY TECHNOLOGY, 2022, 38 (05) : 283 - 288
  • [38] Treatment with Glucagon-Like Peptide-1 Agonist Exendin-4 in a Patient with Hypothalamic Obesity Secondary to Intracranial Tumor
    Simmons, Jill H.
    Shoemaker, Ashley H.
    Roth, Christian L.
    HORMONE RESEARCH IN PAEDIATRICS, 2012, 78 (01): : 54 - 58
  • [39] Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
    Zheng, Zhikai
    Zong, Yao
    Ma, Yiyang
    Tian, Yucheng
    Pang, Yidan
    Zhang, Changqing
    Gao, Junjie
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [40] Effects of treatment with Glucagon-like peptide-1 receptor agonist on prediabetes with overweight/obesity: A systematic review and meta-analysis
    Wang, Weihao
    Wei, Ran
    Huang, Zhengxiang
    Luo, Jingyi
    Pan, Qi
    Guo, Lixin
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2023, 39 (07)
12345